Clendon Biotech Capital

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

Medical

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

August 29, 2025

InhaleRx posts wider half-year loss as clinical trial programs gain momentum

Finance

InhaleRx posts wider half-year loss as clinical trial programs gain momentum

August 26, 2025